BioSpace News Archive

A global data analytics and advisory firm, Quantzig, has announced the release of their latest success story on patient engagement analysis for a leading pharma company.

Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap.

Marathon Health, LLC, a provider of employer healthcare services, today announced Bruce Hochstadt, MD, as executive vice president health center operations and sales. Hochstadt brings more than 20 years of experience in healthcare consulting, strategic partnerships, and product innovations to this new role.

The drug is manufactured by Gilead Sciences under numerous brand names, such as Truvada, Viread, Atripla, Complera and Stribild.

Southcoast Health, with $26.4 million in offshore accounts, proposes closing maternity unit serving hundreds of families per year

Morgan Stanley 17th Annual Global Healthcare Conference to be held at the Grand Hyatt New York, Wednesday, September 11th at 10:30 AM eastern time.

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present a company overview at the Wells Fargo Healthcare Conference in Boston on Thursday, September 5, 2019.

Aflac Incorporated (NYSE: AFL) announced today that Gerardo Monroy has been named senior vice president, Aflac U.S. Innovation Strategy and Execution, reporting to Virgil R. Miller, executive vice president; chief operating officer, Aflac U.S.; president, Aflac Group.

Johnson & Johnson (NYSE: JNJ) will participate in the 2019 Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10th, at The Grand Hyatt Hotel in New York.

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions, today announced that the company will participate in two investor conferences in September.